Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Market Minute: Bed Bath & Beyond Seeks Buyers, Apple's New HomePod & Amazon Fined
Here is a rundown of Cheddar News' top market stories of the day.
Amazon Ends Decade-old Checkout Charity Program
Amazon is discontinuing its decade-old philanthropic program, AmazonSmile, which allowed customers to donate 0.5 percent of the cost of their purchase to select charities.
Cheddar Morning News Briefings of January 19th
Cheddar Morning News Briefings
Morning Alexa Flash Briefings of January 19th
Alexa Flash Briefings
Why the Cost of Eggs and Orange Juice Are Skyrocketing Even as Food Costs Decline
While the cost of food is on the decline, breakfast lovers continue to reel from their dented wallets as the price of eggs and orange juice remain up.
Senate Sets Date For Taylor Swift/Ticketmaster Hearing
The Senate set a Jan. 24 hearing for last year's debacle involving Ticketmaster's sale of Taylor Swift tickets.
Apple Debuts Brand New HomePod
Apple unveiled a new and improved HomePod.
Semafor to Buy Out SBF’s Interest In Company
Semafor plans to buy back Sam Bankman-Fried's $10 million investment in the company.
Volkswagen CEO Talks Record Quarter and Future of EVs
Volkswagen U.S. CEO Pablo Di Si joined Cheddar New to discuss record quarterly electric vehicle sales and his reaction to Tesla trimming prices on some vehicles by 20% last week. “We'll continue with our pricing strategy, we're not cutting prices on the vehicle's quality over quantity and product content,” he said.
